290 related articles for article (PubMed ID: 24583393)
1. Replicative DNA polymerase mutations in cancer.
Heitzer E; Tomlinson I
Curr Opin Genet Dev; 2014 Feb; 24(100):107-13. PubMed ID: 24583393
[TBL] [Abstract][Full Text] [Related]
2. Germline and somatic polymerase ε and δ mutations define a new class of hypermutated colorectal and endometrial cancers.
Briggs S; Tomlinson I
J Pathol; 2013 Jun; 230(2):148-53. PubMed ID: 23447401
[TBL] [Abstract][Full Text] [Related]
3. DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer.
Church DN; Briggs SE; Palles C; Domingo E; Kearsey SJ; Grimes JM; Gorman M; Martin L; Howarth KM; Hodgson SV; ; Kaur K; Taylor J; Tomlinson IP
Hum Mol Genet; 2013 Jul; 22(14):2820-8. PubMed ID: 23528559
[TBL] [Abstract][Full Text] [Related]
4. A panoply of errors: polymerase proofreading domain mutations in cancer.
Rayner E; van Gool IC; Palles C; Kearsey SE; Bosse T; Tomlinson I; Church DN
Nat Rev Cancer; 2016 Feb; 16(2):71-81. PubMed ID: 26822575
[TBL] [Abstract][Full Text] [Related]
5. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.
Palles C; Cazier JB; Howarth KM; Domingo E; Jones AM; Broderick P; Kemp Z; Spain SL; Guarino E; Salguero I; Sherborne A; Chubb D; Carvajal-Carmona LG; Ma Y; Kaur K; Dobbins S; Barclay E; Gorman M; Martin L; Kovac MB; Humphray S; ; ; Lucassen A; Holmes CC; Bentley D; Donnelly P; Taylor J; Petridis C; Roylance R; Sawyer EJ; Kerr DJ; Clark S; Grimes J; Kearsey SE; Thomas HJ; McVean G; Houlston RS; Tomlinson I
Nat Genet; 2013 Feb; 45(2):136-44. PubMed ID: 23263490
[TBL] [Abstract][Full Text] [Related]
6. DNA Polymerase ɛ Deficiency Leading to an Ultramutator Phenotype: A Novel Clinically Relevant Entity.
Castellucci E; He T; Goldstein DY; Halmos B; Chuy J
Oncologist; 2017 May; 22(5):497-502. PubMed ID: 28465371
[TBL] [Abstract][Full Text] [Related]
7. Additive effects of variants of unknown significance in replication repair-associated DNA polymerase genes on mutational burden and prognosis across diverse cancers.
Ying J; Yang L; Yin JC; Xia G; Xing M; Chen X; Pang J; Wu Y; Bao H; Wu X; Shao Y; Zhu L; Cheng X
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34479923
[TBL] [Abstract][Full Text] [Related]
8. In vivo consequences of putative active site mutations in yeast DNA polymerases alpha, epsilon, delta, and zeta.
Pavlov YI; Shcherbakova PV; Kunkel TA
Genetics; 2001 Sep; 159(1):47-64. PubMed ID: 11560886
[TBL] [Abstract][Full Text] [Related]
9. DNA polymerase epsilon and delta proofreading suppress discrete mutator and cancer phenotypes in mice.
Albertson TM; Ogawa M; Bugni JM; Hays LE; Chen Y; Wang Y; Treuting PM; Heddle JA; Goldsby RE; Preston BD
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17101-4. PubMed ID: 19805137
[TBL] [Abstract][Full Text] [Related]
10. Antimutator variants of DNA polymerases.
Herr AJ; Williams LN; Preston BD
Crit Rev Biochem Mol Biol; 2011 Dec; 46(6):548-70. PubMed ID: 21977975
[TBL] [Abstract][Full Text] [Related]
11. Exonuclease 1 preferentially repairs mismatches generated by DNA polymerase α.
Liberti SE; Larrea AA; Kunkel TA
DNA Repair (Amst); 2013 Feb; 12(2):92-6. PubMed ID: 23245696
[TBL] [Abstract][Full Text] [Related]
12. Mutant POLQ and POLZ/REV3L DNA polymerases may contribute to the favorable survival of patients with tumors with POLE mutations outside the exonuclease domain.
Huang F; Tanaka H; Knudsen BS; Rutgers JK
BMC Med Genet; 2020 Aug; 21(1):167. PubMed ID: 32838755
[TBL] [Abstract][Full Text] [Related]
13. Fidelity of mammalian DNA replication and replicative DNA polymerases.
Thomas DC; Roberts JD; Sabatino RD; Myers TW; Tan CK; Downey KM; So AG; Bambara RA; Kunkel TA
Biochemistry; 1991 Dec; 30(51):11751-9. PubMed ID: 1751492
[TBL] [Abstract][Full Text] [Related]
14. Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas.
Spier I; Holzapfel S; Altmüller J; Zhao B; Horpaopan S; Vogt S; Chen S; Morak M; Raeder S; Kayser K; Stienen D; Adam R; Nürnberg P; Plotz G; Holinski-Feder E; Lifton RP; Thiele H; Hoffmann P; Steinke V; Aretz S
Int J Cancer; 2015 Jul; 137(2):320-31. PubMed ID: 25529843
[TBL] [Abstract][Full Text] [Related]
15. Expression of the cancer-associated DNA polymerase ε P286R in fission yeast leads to translesion synthesis polymerase dependent hypermutation and defective DNA replication.
Soriano I; Vazquez E; De Leon N; Bertrand S; Heitzer E; Toumazou S; Bo Z; Palles C; Pai CC; Humphrey TC; Tomlinson I; Cotterill S; Kearsey SE
PLoS Genet; 2021 Jul; 17(7):e1009526. PubMed ID: 34228709
[TBL] [Abstract][Full Text] [Related]
16. Human Pol ε-dependent replication errors and the influence of mismatch repair on their correction.
Agbor AA; Göksenin AY; LeCompte KG; Hans SH; Pursell ZF
DNA Repair (Amst); 2013 Nov; 12(11):954-63. PubMed ID: 24051051
[TBL] [Abstract][Full Text] [Related]
17. POLD1: Central mediator of DNA replication and repair, and implication in cancer and other pathologies.
Nicolas E; Golemis EA; Arora S
Gene; 2016 Sep; 590(1):128-41. PubMed ID: 27320729
[TBL] [Abstract][Full Text] [Related]
18. Characterization of hotspot exonuclease domain mutations in the DNA polymerase ϵ gene in endometrial cancer.
Tian W; Ji Z; Wang J; Meng J; Bi R; Ren Y; Shan B; Yang G; Wang H
Front Oncol; 2022; 12():1018034. PubMed ID: 36313640
[TBL] [Abstract][Full Text] [Related]
19. Nucleotide selectivity defect and mutator phenotype conferred by a colon cancer-associated DNA polymerase δ mutation in human cells.
Mertz TM; Baranovskiy AG; Wang J; Tahirov TH; Shcherbakova PV
Oncogene; 2017 Aug; 36(31):4427-4433. PubMed ID: 28368425
[TBL] [Abstract][Full Text] [Related]
20. Evidence for interplay among yeast replicative DNA polymerases alpha, delta and epsilon from studies of exonuclease and polymerase active site mutations.
Pavlov YI; Maki S; Maki H; Kunkel TA
BMC Biol; 2004 May; 2():11. PubMed ID: 15163346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
